News
VivoSim Labs, Inc. (the "Company" or "VivoSim") announced today that its NAMkindtm platform for intestinal efficacy prediction was recognized with a blue ribbon "Poster of Distinction" award at the ...
POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity Evaluation of ...
A simple MRI scan can save lives, detecting everything from injuries to cancer and strokes. But, in the world of "Final ...
Customers have been urged not to eat the food and return them to the store they were bought from for a full refund.
Interim data from ENERGY 3 trial highlight INZ-701's potential to modify disease course in ENPP1 Deficiency, with sustained ...
There’s homegrown price fixing and grocery monopolies, right here in Canada, thanks to our very own corporate chains milking ...
Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...
20h
Medindia on MSNIs Inclusivity the New Hero of Clinical Trials?Celebrates clinical research professionals and their global impact on healthcare innovation * Focuses on inclusivity in ...
Held at the MRCG Fajara campus under the theme-‘Labs Save Lives’, the event offered young learners a unique opportunity to ...
Mysuru: Insofar, there has been a sharp decline in the number of dengue and chikungunya cases reported in Mysuru district, ...
To celebrate the beginning of our 20th year, we’ve set out to catalogue the contributions that Pittsburgh and western ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results